Largest single-institution series of robotic pneumonectomy
-
By
-
Ammar Asban
-
Nikolaos Pachos
-
Caroline A. Snyder
-
Isabella Ferraro
-
Stephanie Chang
-
Costas Bizekis
-
Robert J. Cerfolio
-
Michael D. Zervos
-
June 24, 2026
-
Clinical Scorecard: Comprehensive Analysis of the Largest Consecutive Robotic Pneumonectomy Series at a Single Institution
At a Glance
| Category | Detail |
|---|
| Condition | Robotic Pneumonectomy |
| Key Mechanisms | Minimally invasive surgical approach using robotic platforms. |
| Target Population | Patients undergoing pneumonectomy, primarily for lung cancer. |
| Care Setting | Single-institution surgical practice. |
Key Highlights
- 21 patients with a median age of 70, predominantly male (67%).
- Indication for pneumonectomy was cancer in 81% of cases.
- 30-day morbidity rate was 19%, with no 30-day mortality.
- 90-day mortality rate was 5%, with a median length of stay of 5 days.
- Robotic approach resulted in minimal unplanned conversions to thoracotomy.
Guideline-Based Recommendations
Diagnosis
- Patients evaluated in a multidisciplinary thoracic oncology conference.
Management
- Consideration for surgical resection after induction systemic therapy.
Monitoring & Follow-up
- Postoperative outcomes include length of stay, complications, and readmission rates.
Risks
- Conversion-to-thoracotomy rates reported at 30%-50%.
Patient & Prescribing Data
Patients with locally advanced NSCLC or destroyed lungs from infection.
Neoadjuvant therapy included chemotherapy, immunotherapy, and radiation.
Clinical Best Practices
- Utilization of the da Vinci Xi Surgical System for robotic procedures.
- Assessment of patients for surgical candidacy based on comprehensive evaluation.
Related Resources & Content
